0001104659-16-159958.txt : 20161201 0001104659-16-159958.hdr.sgml : 20161201 20161201104805 ACCESSION NUMBER: 0001104659-16-159958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161130 FILED AS OF DATE: 20161201 DATE AS OF CHANGE: 20161201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibbs Michael Terrence CENTRAL INDEX KEY: 0001665000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 162027300 MAIL ADDRESS: STREET 1: 12 STONEY BROOK RD. CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 a4.xml 4 X0306 4 2016-11-30 0 0001492674 T2 Biosystems, Inc. TTOO 0001665000 Gibbs Michael Terrence 101 HARTWELL AVENUES LEXINGTON MA 02421 0 1 0 0 General Counsel Restricted Stock Units 2016-11-30 4 A 0 13000 0 A Common Stock 13000 13000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments beginning on November 30, 2017. Vested shares will be delivered to the reporting person fourteen months after the vesting date. /s/ Shawn Lynch, Attorney-in-Fact 2016-11-30